Your browser doesn't support javascript.
loading
Optimization of process parameters for specific pathogen-free chicken embryonic fibroblast cultivation for yellow fever vaccine production.
Narreddy, Hareesh Reddy; Kondapalli, Ratna Prakash; Tc, Venkateswarulu.
Afiliação
  • Narreddy HR; Department of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, India.
  • Kondapalli RP; Biological E Limited, Hyderabad, India.
  • Tc V; Department of Biotechnology, Vignan's Foundation for Science, Technology and Research, Guntur, India.
Prep Biochem Biotechnol ; : 1-7, 2024 Jul 25.
Article em En | MEDLINE | ID: mdl-39049774
ABSTRACT
The yellow fever (YF) vaccine is usually produced with egg-based methods, which has limitations, including potential adverse effects and low production yields. Alternatively, producing the vaccine using Vero cells or HEK 293 cells can overcome some of these issues, but these methods are significantly more expensive. In the current study, the YF vaccine candidate 17DD virus was produced in primary chicken embryo fibroblast (CEF) cells. The primary CEF cells isolation from eggs was optimized through a two-step process. In the first step, the important parameters that contribute to the development of the egg embryo, such as egg position, relative humidity (RH), and incubation time are optimized. In second step, primary CEF release parameters namely; trypsin volume and incubation temperature are optimized. Both steps were optimized using statistical methods. Further, the seeding cell density of isolated CEF was also optimized. It was observed that 5 x 104 cells/cm2 gave the highest virus titer of 3.89 million PFU/ml. The 17DD yields achieved in primary CEFs are much higher than egg-based production and it is an economically viable method.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article